Info

OTCQB Podcast

OTC Markets Group podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.
RSS Feed
OTCQB Podcast
2022
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February


2017
December
November
October
September
August
July
June
May
April
March
January


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Apr 29, 2020

Humanigen, Inc. (OTCQB: HGEN) is a biopharmaceutical company developing its portfolio of next-generation cell and gene therapies for the treatment of cancers via its novel, GM-CSF neutralization, and gene-knockout platforms. We welcome back Chairman & CEO of Humanigen, Cameron Durrant, MD, MBA, to explain the significance of “GM-CSF” pathway science for COVID-19 patients.

0 Comments
Adding comments is not available at this time.